Showing results (301-310 of 464) with videos related to

Sort By:
Pageof 47
Elife|July 29, 2021
A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53Liz Hernandez Borrero, David T Dicker, John Santiago, et al.
Cancer Research|November 20, 2013
Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53Bo Hong, Varun V Prabhu, Shengliang Zhang, et al.
Cancer Biology & Therapy|October 28, 2005
Non-invasive fluorescence imaging of cell death in fresh human colon epithelia treated with 5-Fluorouracil, CPT-11 and/or TRAILNiklas Finnberg, Seok-Hyun Kim, Emma E Furth, et al.
Molecular Cell|November 18, 2009
GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stressTakao Ide, Lauren Brown-Endres, Kiki Chu, et al.
Cancer Biology & Therapy|December 2, 2005
Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosisPaul G Corn, M Stacey Ricci, Kimberly A Scata, et al.
Cancer Research|March 12, 2014
COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulationJoshua E Allen, Akshal S Patel, Varun V Prabhu, et al.
Blood|December 1, 1994
Absence of WAF1 mutations in a variety of human malignanciesM Shiohara, W S el-Deiry, M Wada, et al.
Cancer Research|May 1, 1998
p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alphaM S Sheikh, T F Burns, Y Huang, et al.
Cancer Research|September 23, 2003
Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cellsEugene A Choi, Hanqin Lei, David J Maron, et al.
Oncotarget|June 17, 2025
Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatmentAlberto Hernando-Calvo, Razelle Kurzrock, Nadia Saoudi Gonzalez, et al.
Pageof 47